Moon, Da Ru Chi <br/><br/>
Aflibercept Treatment for Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy Refractory to Anti-vascular Endothelial Growth Factor.  [electronic resource] 

 -  Korean journal of ophthalmology : KJO  08 2015 
 - 226-32 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2092-9382 
<br/><br/><label>Standard No.: </label>10.3341/kjo.2015.29.4.226  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--administration & dosage<br/>Bevacizumab--administration & dosage<br/>Choroid--blood supply<br/>Choroid Diseases--complications<br/>Dose-Response Relationship, Drug<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Intravitreal Injections<br/>Male<br/>Ranibizumab--administration & dosage<br/>Receptors, Vascular Endothelial Growth Factor--administration & dosage<br/>Recombinant Fusion Proteins--administration & dosage<br/>Retinal Neovascularization--complications<br/>Retrospective Studies<br/>Tomography, Optical Coherence<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity<br/>Wet Macular Degeneration--diagnosis